Savings Offer

Help your eligible patients pay as little as $4 per 30-day fill for brand-name CELEBREX.

For more information on the Savings Offer click here.

Terms and Conditions  
*Eligibility required. Terms and conditions apply. Full terms and conditions can be found at Celebrex.com/savings-termsThis Savings Offer will be accepted only at participating pharmacies. This Savings Offer is not health insurance. No membership fees. Maximum savings of $2,800 per calendar year. This Savings Offer is not valid for prescriptions that are eligible to be reimbursed, in whole or in part, by Medicaid, Medicare, or other federal or state healthcare programs. This Savings Offer is not valid for prescriptions that are eligible to be reimbursed in whole by private insurance plans or other health or pharmacy benefit programs. Viatris reserves the right to revoke, rescind, or amend this offer without notice. For help with the CELEBREX Savings Offer, call 1-855-612-1956, visit CELEBREX.com, or write: Viatris, P.O. Box 2941, Mission, KS 66201.

CELEBREX is a registered trademark of G.D. Searle LLC, a Viatris Company.

PP-CEL-USA-0632

Dosing & Administration

  • Use the lowest effective dosage for shortest duration consistent with individual patient treatment goals.
  • Osteoarthritis (OA): 200 mg once daily or 100 mg twice daily.
  • Rheumatoid Arthritis (RA): 100 mg to 200 mg twice daily.
  • Juvenile Rheumatoid Arthritis (JRA): 50 mg twice daily in patients 10 kg to 25 kg. 100 mg twice daily in patients more than 25 kg.
  • Ankylosing Spondylitis (AS): 200 mg once daily single dose or 100 mg twice daily. If no effect is observed after 6 weeks, a trial of 400 mg (single or divided doses) may be of benefit.
  • Acute Pain (AP) and Primary Dysmenorrhea (PD): 400 mg initially, followed by 200 mg dose if needed on first day. On subsequent days, 200 mg twice daily as needed.

Hepatic Impairment: Reduce daily dose by 50% in patients with moderate hepatic impairment (Child-Pugh Class B).

Poor Metabolizers of CYP2C9 Substrates: Consider a dose reduction by 50% (or alternative management for JRA) in patients who are known or suspected to be CYP2C9 poor metabolizers.

CELEBREX is available as 50 mg, 100 mg, 200 mg, and 400 mg capsules.

CELEBREX is a registered trademark of G.D. Searle LLC, a Viatris Company.

PP-CEL-USA-0632

Help Keep Rx As Prescribed

To help ensure the brand you prescribe is dispensed as written at the pharmacy, write "Dispense as Written" (DAW)* on your next CELEBREX prescription.

*Prescription language and requirements may vary based on your state's law.

CELEBREX is a registered trademark of G.D. Searle LLC, a Viatris Company.

PP-CEL-USA-0632

Resources

CELEBREX continues to provide resources for patients.

For more information on the resources click here.

CELEBREX is a registered trademark of G.D. Searle LLC, a Viatris Company.

PP-CEL-USA-0632